Home » CYTORI THERAPEUTICS COMPLETES DEVELOPMENT OF THE CELUTION SYSTEM
CYTORI THERAPEUTICS COMPLETES DEVELOPMENT OF THE CELUTION SYSTEM
Cytori Therapeutics, Inc. (Frankfurt: XMP), today announced it has completed the development of its Celution(TM) System for the isolation and concentration of adipose stem cells and will submit CE Mark application seeking approval for the system in Europe.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1032552XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May